Hans-Juergen Woerle, VP at Boehringer Ingelheim, to Speak at Diabetes Summit, April 2012 Boston
Hans-Juergen Woerle, MD, Associate Professor, Internal Medicine, Vice President and Head of Therapeutic Area Metabolism at Boehringer Ingelheim, Ingelheim, Germany, will be giving a plenary keynote presentation entitled “Diabetes Drug Development in Light of the New FDA CV Guidance: Experience from the Recent Linagliptin Registration” at the 2nd Diabetes Summit to be held on April 19-20, 2012 in Boston, MA by GTC.
View full press release